• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Just Ask the Expert: Is ace not so ace for examining patients with fear aggression?

May 21, 2019
Julia Albright, MA, DVM, DACVB
dvm360, dvm360 July 2019, Volume 50, Issue 6

This veterinary behaviorist says that while acepromazine may make patients more tractable in the clinic, its likely doing nothing to reduce their anxiety.

Question: Why shouldn't acepromazine be a go-to sedative to help manage fear aggression in dogs during physical examinations? Which medications are good alternatives to consider?

Answer: Psychopharmacology can be a confusing and overwhelming subject in veterinary medicine, in large part due to the wide individual variation in observable effects and the overlap in clinical applications. Another factor is the current paradigm shift from drugs that simply produce behavioral suppression and decreased motor activity to those that have antianxiety properties as well.

Acepromazine is an antipsychotic, a class of drugs originally used to treat psychoses such as schizophrenia in humans by blocking the action of dopamine, a catecholamine neurotransmitter. More specifically, acepromazine is a low-potency phenothiazine neuroleptic drug and, like most of the older antipsychotics used in veterinary medicine (including haloperidol and fluphenazine as well as acepromazine), it blocks all the dopamine pathways responsible for cognition, motivation and motor coordination. Acepromazine affects other physiologic systems as well and can cause cardiovascular, motor and endocrine side effects.

Find more help here

There are many resources available for specific medication choices and doses as well as for helping the veterinary team and clients create a counterconditioning protocol for long-term improvement.

Though acepromazine is generally safe and can ease handling by blunting behavioral responses, it has fallen out of favor, especially as an oral monotherapy, due to numerous reports of sedation without acceptable reduction in signs of fear or anxiety.

Advertisement

So, to answer the specific question about the use of acepromazine to manage fear-related aggression, acepromazine may make the animal more tractable for handling, but it's unlikely to be addressing the underlying fear. Other medications such as benzodiazepines, gabapentin, the atypical antidepressant trazodone, and norepinephrine release blockers like dexmedetomidine are more likely to create emotional calmness (again, primarily based on body language assessment) with or without sedation.

My clients and consulting general practitioners are looking for the silver bullet tablet to help make veterinary visits go more smoothly. Unfortunately, fast-acting situational oral drugs can have variable effects due to several factors. Most of these drugs have reduced bioavailability compared to other administration routes due to the hepatic first pass effect. In addition, many of our patients are experiencing an extreme level of distress during the average clinic visit, and single administration of most of these medications is simply not effective in the face of such acute physiologic arousal.

In my practice, once we've identified a fearful patient, I have the clients conduct a trial of two to three medications at home-usually some combination of those discussed above. We monitor for gastrointestinal or agitation side effects and adjust doses until we reach the desired clinic effect with few to no side effects. Acepromazine may be one of the medications we use in the cocktail, but that is rare these days.

For most of my aggressive patients, the goal of client-administered pre-visit medications is to produce enough sedation and relaxation to allow the team to administer a low-stress intramuscular injection of additional medications for a more thorough physical exam or other procedures. However, occasionally we feel the patient is comfortable enough to continue our visit with just the oral medications.

Either way, when the patient is calm in the veterinary clinic-and not just still-the team can do what it needs to do to optimize physical health without harming emotional wellbeing. And everyone feels better about that.

Dr. Julia Albright is assistant professor of veterinary behavior and PetSafe Chair of Small Animal Behavioral Research at the University of Tennessee's College of Veterinary Medicine.

download issueDownload Issue: dvm360 July 2019

Related Content:

AssociatesProductsBehaviorTechniciansdvm360 July 2019
To refer or not to refer
To refer or not to refer
New Hawaii-based pet CBD brand launches
New Hawaii-based pet CBD brand launches
Updated EquiTrace app integrates wth HISA Portal
Updated EquiTrace app integrates wth HISA Portal

Advertisement

Latest News

Morris Animal Foundation appoints new chief program officer

CDC issues warning over cat-transmitted sporotrichosis

An AI solution is speeding up insurance claims processing

3 categories of inappetence in dogs

View More Latest News
Advertisement